Gujarat Terce Laboratories Limited (GUJTERC.BO)
INR 55.46
(2.21%)
INR 55.46
(2.21%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 38.66 Million INR | -46.83% |
| 2022 | 72.72 Million INR | 9.0% |
| 2021 | 66.71 Million INR | 40.84% |
| 2020 | 47.37 Million INR | 82.49% |
| 2019 | 25.95 Million INR | 280.93% |
| 2018 | 6.81 Million INR | 84.82% |
| 2017 | 3.68 Million INR | -94.73% |
| 2016 | 69.93 Million INR | -1.89% |
| 2015 | 71.27 Million INR | -13.18% |
| 2014 | 82.1 Million INR | -6.09% |
| 2013 | 87.42 Million INR | -3.8% |
| 2012 | 90.88 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q4 | - INR | -100.0% |
| 2023 Q1 | 72.72 Million INR | 0.0% |
| 2023 Q2 | - INR | -100.0% |
| 2023 Q3 | 57.08 Million INR | 0.0% |
| 2023 FY | 38.66 Million INR | -46.83% |
| 2022 Q4 | - INR | -100.0% |
| 2022 FY | 72.72 Million INR | 9.0% |
| 2022 Q1 | 66.71 Million INR | 0.0% |
| 2022 Q2 | - INR | -100.0% |
| 2022 Q3 | 76.4 Million INR | 0.0% |
| 2021 Q1 | 47.37 Million INR | 0.0% |
| 2021 FY | 66.71 Million INR | 40.84% |
| 2021 Q2 | - INR | -100.0% |
| 2021 Q3 | 41.07 Million INR | 0.0% |
| 2021 Q4 | - INR | -100.0% |
| 2020 FY | 47.37 Million INR | 82.49% |
| 2020 Q4 | - INR | -100.0% |
| 2020 Q3 | 36.8 Million INR | 0.0% |
| 2020 Q2 | - INR | -100.0% |
| 2020 Q1 | 25.95 Million INR | 0.0% |
| 2019 Q2 | - INR | -100.0% |
| 2019 Q1 | 6.81 Million INR | 0.0% |
| 2019 FY | 25.95 Million INR | 280.93% |
| 2019 Q4 | - INR | -100.0% |
| 2019 Q3 | 22.13 Million INR | 0.0% |
| 2018 Q2 | - INR | -100.0% |
| 2018 Q1 | 3.4 Million INR | 0.0% |
| 2018 FY | 6.81 Million INR | 84.82% |
| 2018 Q3 | 23.32 Million INR | 0.0% |
| 2018 Q4 | - INR | -100.0% |
| 2017 FY | 3.68 Million INR | -94.73% |
| 2017 Q1 | 69.93 Million INR | 0.0% |
| 2017 Q2 | - INR | -100.0% |
| 2017 Q3 | 12.64 Million INR | 0.0% |
| 2016 Q3 | 64.67 Million INR | 0.0% |
| 2016 Q1 | 71.27 Million INR | 0.0% |
| 2016 Q4 | - INR | -100.0% |
| 2016 FY | 69.93 Million INR | -1.89% |
| 2015 Q1 | 80.93 Million INR | 0.0% |
| 2015 FY | 71.27 Million INR | -13.18% |
| 2015 Q4 | - INR | -100.0% |
| 2015 Q2 | - INR | -100.0% |
| 2015 Q3 | 84.59 Million INR | 0.0% |
| 2014 Q3 | 31.74 Million INR | 0.0% |
| 2014 Q4 | - INR | -100.0% |
| 2014 FY | 82.1 Million INR | -6.09% |
| 2014 Q1 | 86.11 Million INR | 0.0% |
| 2014 Q2 | - INR | -100.0% |
| 2013 Q1 | 89.42 Million INR | 0.0% |
| 2013 FY | 87.42 Million INR | -3.8% |
| 2013 Q2 | - INR | -100.0% |
| 2013 Q4 | - INR | -100.0% |
| 2013 Q3 | 91.88 Million INR | 0.0% |
| 2012 FY | 90.88 Million INR | 0.0% |
| 2012 Q3 | 119.55 Million INR | 0.0% |
| 2010 Q1 | 30.75 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| ANG Lifesciences India Limited | 728.36 Million INR | 94.692% |
| Add-Shop E-Retail Limited | 127.73 Million INR | 69.731% |
| Bacil Pharma Limited | 984 Thousand INR | -3829.37% |
| Beryl Drugs Limited | 50.93 Million INR | 24.095% |
| Cian Healthcare Limited | 556.91 Million INR | 93.057% |
| Colinz Laboratories Limited | 5.69 Million INR | -578.571% |
| Concord Drugs Limited | 165.94 Million INR | 76.7% |
| Deccan Health Care Limited | 18.95 Million INR | -104.026% |
| Gennex Laboratories Limited | 57.2 Million INR | 32.41% |
| Ishita Drugs and Industries Limited | - INR | -Infinity% |
| Kerala Ayurveda Limited | 675.77 Million INR | 94.278% |
| Kwality Pharmaceuticals Limited | 981.19 Million INR | 96.059% |
| Mercury Laboratories Limited | 55.53 Million INR | 30.378% |
| Panchsheel Organics Limited | 63.09 Million INR | 38.716% |
| Parmax Pharma Limited | 53.72 Million INR | 28.029% |
| Parnax Lab Limited | 806.38 Million INR | 95.205% |
| Patidar Buildcon Limited | 25.32 Million INR | -52.687% |
| Pharmaids Pharmaceuticals Limited | 85.32 Million INR | 54.687% |
| Phaarmasia Limited | 1.44 Million INR | -2583.206% |
| Sandu Pharmaceuticals Limited | 633 Thousand INR | -6008.215% |
| Sastasundar Ventures Limited | 38.82 Million INR | 0.42% |
| SHELTER PHARMA LIMITED | 5.77 Million INR | -569.756% |
| Source Natural Foods and Herbal Supplements Limited | 35 Thousand INR | -110371.429% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 96.312% |
| Sunil Healthcare Limited | 661.51 Million INR | 94.155% |
| Syschem (India) Limited | 4.5 Million INR | -759.222% |
| Trident Lifeline Limited | 184.1 Million INR | 78.998% |
| Transchem Limited | - INR | -Infinity% |
| Tyche Industries Limited | - INR | -Infinity% |
| Vikram Thermo (India) Limited | 70.43 Million INR | 45.107% |
| Vasundhara Rasayans Limited | 19.46 Million INR | -98.639% |
| Zenith Healthcare Limited | - INR | -Infinity% |
| Zenotech Laboratories Limited | - INR | -Infinity% |
| Hindustan Bio Sciences Limited | 25.56 Million INR | -51.251% |
| KIMIA BIOSCIENCES LIMITED | 437.07 Million INR | 91.154% |
| Chemo Pharma Laboratories Limited | - INR | -Infinity% |
| MedPlus Health Services Limited | 10.09 Billion INR | 99.617% |
| Sanjivani Paranteral Limited. | 9.69 Million INR | -298.978% |
| Smruthi Organics Limited | 117.03 Million INR | 66.963% |
| Trimurthi Limited | - INR | -Infinity% |
| Zenlabs Ethica Limited | 148.59 Million INR | 73.98% |
| Makers Laboratories Limited | 194.92 Million INR | 80.164% |
| Lactose (India) Limited | 392.52 Million INR | 90.15% |
| Bharat Immunologicals & Biologicals Corporation Limited | 702.24 Million INR | 94.494% |
| Roopa Industries Limited | 258.54 Million INR | 85.045% |
| PANJON LTD. | 14.36 Million INR | -169.086% |
| TIAAN CONSUMER LIMITED | 14.8 Million INR | -161.25% |
| Anuh Pharma Limited | 26.92 Million INR | -43.587% |
| Crestchem Limited | - INR | -Infinity% |
| Emmessar Biotech & Nutrition Limited | 1.09 Million INR | -3434.278% |
| PRAVEG LIMITED | 596.11 Million INR | 93.514% |
| Fredun Pharmaceuticals Limited | 1.05 Billion INR | 96.335% |
| Shukra Pharmaceuticals Limited | 31.53 Million INR | -22.594% |
| Norris Medicines Limited | 215.23 Million INR | 82.036% |
| Denis Chem Lab Limited | 10.46 Million INR | -269.646% |
| Veerhealth Care Limited | - INR | -Infinity% |
| Jenburkt Pharmaceuticals Limited | - INR | -Infinity% |
| OXYGENTA PHARMACEUTICAL LIMITE | 572.33 Million INR | 93.244% |
| Godavari Drugs Limited | 556.24 Million INR | 93.049% |
| SHAMROCK INDUSTRIAL CO.LTD. | - INR | -Infinity% |
| Ambalal Sarabhai Enterprises Limited | 461.12 Million INR | 91.615% |
| Vivanza Biosciences Limited | 51.69 Million INR | 25.206% |
| Medi-Caps Limited | - INR | -Infinity% |
| DECIPHER LABS LIMITED | - INR | -Infinity% |
| Shree Ganesh Remedies Limited | 364.49 Million INR | 89.392% |
| Gujarat Themis Biosyn Limited | 27.68 Million INR | -39.666% |
| Bharat Parenterals Limited | 1.57 Billion INR | 97.546% |
| BDH Industries Limited | 86.9 Million INR | 55.51% |
| Vista Pharmaceuticals Limited | 79.64 Million INR | 51.455% |
| Coral Laboratories Limited | - INR | -Infinity% |
| Evoq Remedies Limited | 42.38 Million INR | 8.77% |
| Trinity League India Limited | 242 Thousand INR | -15877.273% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 97.232% |
| Natural Capsules Limited | 1.09 Billion INR | 96.453% |
| Auro Laboratories Limited | 262.43 Million INR | 85.267% |